The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Highly Active Antiretroviral Therapy and the Incidence of Non–AIDS-Defining Cancers in People With HIV Infection
Abstract
Purpose: The effect of highly active antiretroviral therapy (HAART) on the incidence of non–AIDS-defining cancers (NADCs) is unclear. Methods: We have investigated the occurrence of NADCs in a prospective cohort of 11,112 HIV-positive individuals, with 71,687 patient-years of follow-up. Standardized incidence ratios (SIRs) were calculated using general population incidence data. We investigated the effect of calendar period, HIV parameters, and immunologic and treatment-related factors on the incidence of these cancers using univariate and multivariate analyses. Results: The SIR for all NADCs was 1.96 (95% CI, 1.66 to 2.29). There was no significant excess in incidence in the pre-HAART era (1983 to 1995; SIR, 0.95; 95% CI, 0.58 to 1.47). However, the incidence increased in the early HAART period (1996 to 2001) and remains elevated in the most recent established HAART period (2002 to 2007; SIR, 2.05; 95% CI, 1.51 to 2.72, and SIR 2.49; 95% CI, 2.00 to 3.07, respectively). Multivariate analysis showed that use of HAART (hazard ratio [HR] = 1.64; 95% CI, 1.13 to 2.39) and a nadir CD4 count less than 200/μL (HR = 1.67; 95% CI, 1.10 to 2.54) were associated with an increased risk. Only the non-nucleoside reverse transcriptase inhibitors (NNRTIs) were associated with a significantly increased risk of NADCs (HR = 1.45; 95% CI, 1.01 to 2.08). Much of this association was attributable to an increased risk of Hodgkin's lymphoma with NNRTIs (HR = 2.20; 95% CI, 1.03 to 4.69). Conclusion: Since the introduction of HAART, there has been a significantly increased risk of NADCs, which has now stabilized. A number of factors are associated with this increased risk, including HAART use. There may be an association between the use of NNRTIs and the development of Hodgkin's lymphoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grulich, A. E., van Leeuwen, M. T., Falster, M. O., & Vajdic, C. M. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61050-2 · Cited by 2,323
Gazzard, B., & on behalf of the BHIVA Treatment Guidelines Writing Group (2008) · HIV Medicine · doi:10.1111/j.1468-1293.2008.00636.x · Cited by 1,089
Self-citationTreatment for Adult HIV Infection: 2006 Recommendations of the International AIDS Society–USA Panel
Hammer, S. M., Saag, M. S., Schechter, M., Montaner, J. S. G., Schooley, R. T., Jacobsen, D. M., Thompson, M. A., Carpenter, C. C. J., Fischl, M. A., Gazzard, B. G., et al. (2006) · JAMA · doi:10.1001/jama.296.7.827 · Cited by 1,033
Self-citationPatel, P., Hanson, D. L., Sullivan, P. S., Novak, R. M., Moorman, A. C., Tong, T. C., Holmberg, S. D., Brooks, J. T., & for the Adult and Adolescent Spectrum of Disease Project and HIV Outpatient Study Investigators* (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-10-200805200-00005 · Cited by 942
Clifford, G. M., Polesel, J., Rickenbach, M., Study, O. B. O. T. S. H. C., Dal Maso, L., Keiser, O., Kofler, A., Rapiti, E., Levi, F., Jundt, G., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji072 · Cited by 863
Association of Cancer With AIDS-Related Immunosuppression in Adults
Frisch, M. (2001) · JAMA · doi:10.1001/jama.285.13.1736 · Cited by 821
Trends in cancer risk among people with AIDS in the United States 1980–2002
Engels, E. A., Pfeiffer, R. M., Goedert, J. J., Virgo, P., McNeel, T. S., Scoppa, S. M., & Biggar, R. J. (2006) · AIDS · doi:10.1097/01.aids.0000238411.75324.59 · Cited by 775
International Collaboration on HIV and Cancer (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.22.1823 · Cited by 647
Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS
Biggar, R. J., Jaffe, E. S., Goedert, J. J., Chaturvedi, A., Pfeiffer, R., Engels, E. A., & Study, F. T. H. C. M. (2006) · Blood · doi:10.1182/blood-2006-05-024109 · Cited by 436
HIV Infection Is Associated with an Increased Risk for Lung Cancer, Independent of Smoking
Kirk, G. D., Merlo, C., O'Driscoll, P., Mehta, S. H., Galai, N., Vlahov, D., Samet, J., & Engels, E. A. (2007) · Clinical Infectious Diseases · doi:10.1086/518606 · Cited by 387
Herida, M., Mary-Krause, M., Kaphan, R., Cadranel, J., Poizot-Martin, I., Rabaud, C., Plaisance, N., Tissot-Dupont, H., Boue, F., Lang, J.-M., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.01.096 · Cited by 339
Gills, J. J., LoPiccolo, J., Tsurutani, J., Shoemaker, R. H., Best, C. J. M., Abu-Asab, M. S., Borojerdi, J., Warfel, N. A., Gardner, E. R., Danish, M., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0161 · Cited by 320
Hammer, S. M., Saag, M. S., Schechter, M., Montaner, J. S. G., Schooley, R. T., Jacobsen, D. M., Thompson, M., Carpenter, C. C. J., Fischl, M. A., Gazzard, B., et al. (2006) · PubMed · Cited by 315
Self-citationHIV-related lung cancer in the era of highly active antiretroviral therapy
Bower, M., Powles, T., Nelson, M. R., Shah, P. L., Cox, S., Mandelia, S., & Gazzard, B. (2003) · AIDS · doi:10.1097/00002030-200302140-00011 · Cited by 149
Self-citationBHIVA Writing Committee on behalf of the BHIVA Executive Committee (2001) · HIV Medicine · doi:10.1046/j.1464-2662.2001.00083.x · Cited by 141
Serraino, D., Piselli, P., BUSNACH, G., et al. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2007.07.015 · Cited by 125
Cancer Risk Among Participants in the Women???s Interagency HIV Study
Hessol, N. A., Seaberg, E. C., Preston‐Martin, S., Massad, L. S., Sacks, H. S., Silver, S., Melnick, S. L., Abulafia, O., & Levine, A. M. (2004) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200408010-00013 · Cited by 96
Dynamics of Epstein–Barr virus in HIV-1-infected subjects on highly active antiretroviral therapy
Righetti, E., Ballon, G., Ometto, L., Cattelan, A. M., Menin, C., Zanchetta, M., Chieco‐Bianchi, L., & Rossi, A. D. (2002) · AIDS · doi:10.1097/00002030-200201040-00009 · Cited by 88
Zidovudine induces S-phase arrest and cell cycle gene expression changes in human cells
Olivero, O. A., Tejera, Á. M., Fernandez, J. J., Taylor, B. J., Das, S., Divi, R. L., & Poirier, M. C. (2005) · Mutagenesis · doi:10.1093/mutage/gei019 · Cited by 56
Cited by
Cancer Burden in the HIV-Infected Population in the United States
Shiels, M. S., Pfeiffer, R. M., Gail, M. H., Hall, H. I., Li, J., Chaturvedi, A. K., Bhatia, K., Uldrick, T. S., Yarchoan, R., Goedert, J. J., et al. (2011) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djr076 · Cited by 778
Guiguet, M., Boué, F., Cadranel, J., Lang, J.-M., Rosenthal, E., & Costagliola, D. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70282-7 · Cited by 571
A Meta-Analysis of the Incidence of Non-AIDS Cancers in HIV-Infected Individuals
Shiels, M. S., Cole, S. R., Kirk, G. D., & Poole, C. (2009) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181b327ca · Cited by 516
Beyer, J., Albers, P., Altena, R., Aparicio, J., Bokemeyer, C., Busch, J., Cathomas, R., Cavallin-Stahl, E., Clarke, N. W., Claßen, J., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mds579 · Cited by 320
Self-citationStudy, T. S. H. C., Franceschi, S., Lise, M., Clifford, G. M., Rickenbach, M., Levi, F., Maspoli, M., Bouchardy, C., Dehler, S., Jundt, G., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605756 · Cited by 307
Metadata
- Authors
- Powles, T., Robinson, D., Stebbing, J., Shamash, J., Nelson, M., Gazzard, B., Mandelia, S., Møller, H., & Bower, M.
- Venue
- Journal of Clinical Oncology
- Published
- 2009-02-20
- Volume
- 27
- Issue
- 6
- Pages
- 884-890
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2006152917
- Cited by
- 360
- References
- 19
- FWCI
- 11.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.